Researchers define mechanism that causes kidney cancer to recur

October 23, 2017
 

Work could lead to making cancer cells sensitive to drug treatment

Read more

UT Health San Antonio researchers define mechanism that causes kidney cancer to recur

October 23, 2017
 

SAN ANTONIO (Oct. 23, 2017) ― New research from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and U.S. Department of Veterans Affairs has identified the molecular mechanism that causes kidney cancer to resist drug treatment. The findings were published Oct. 19 in the journal Nature Communications. In normal […]

Read more


UT Cancer Center testing new drug for HER2-positive breast cancer

October 10, 2017
 

UT Health Cancer Center seeking participants for a clinical trial to evaluate a new drug called tucatinib, an oral medication that can be taken at home.

Read more


Brain

UT Cancer Center testing new drug for HER2-positive breast cancer

October 9, 2017
 

October is Breast Cancer Awareness Month; National Metastatic Breast Cancer Awareness Day is Oct. 13 SAN ANTONIO (Oct. 9, 2017) ― Teresa Wallace, 52, is an accountant from Alton, Texas, in the Rio Grande Valley. She is working less with numbers and doing far fewer craft projects after being diagnosed with HER2-positive breast cancer in 2013. […]

Read more


San Antonio Combat PTSD Conference

Second Annual San Antonio Combat PTSD Conference to feature latest research, leaders in the field

October 6, 2017
 

SAN ANTONIO (Oct. 6, 2017) ― Top researchers from around the country will join mental health professionals and others interested in improving care for the psychological wounds of war at the Second Annual San Antonio Combat PTSD Conference on Oct. 18-19. Presented by the STRONG STAR Consortium and Consortium to Alleviate PTSD (CAP), two federally […]

Read more


Brain

Study shows major improvement in children’s ADHD symptoms

October 2, 2017
 

New formulation of established medication significantly improves severe morning symptoms.

Read more